Company: IXHL
Filing Date: 2025-10-27
Form Type: DEF 14A
Source: 0001213900-25-102654
Chunk: 18

Company: Incannex Healthcare Inc.
Filing Date: 2025-10-27
Form: DEF 14A
Chunk 18
---
                               
 proxy statement and form of proxy and, if elected, to serve on the registrant’s board of directors; |

| ● | a statement that, to the best of the nominating stockholder’s                                                  
 or group’s knowledge the nominee meets the objective criteria for “independence” applicable to the registrant; |

| ● | certain biographical information concerning the proposed nominee; |

| ● | all information concerning the proposed nominee required to         
 be disclosed in solicitations of proxies for election of directors; |

| ● | certain information about any other security holder of the Company 
 who supports the proposed nominee;                                 |

| ● | a description of all relationships between the proposed nominee                                                                         
 the recommending stockholder or any beneficial owner and/or the registrant or any affiliate of the registrant, including any agreements 
 or understandings regarding the nomination; and                                                                                         |

| ● | any additional disclosures relating to stockholder nominees                                         
 for directors, including completed questionnaires and disclosures as may be required by our bylaws. |

Board Leadership Structure and Role in Risk Oversight Our board of directors is responsible for the control and direction of the Company. At present, the board of directors has elected to separate the positions of Chairperson and Chief Executive Officer. Mr. Latham serves as Chief Executive Officer of the Company and as a member of our board of directors. Mr. Valentine serves as the Chairperson of our board of directors. Our board of directors believes that this structure serves the Company well by maintaining a link between management, through Mr. Latham’s membership on our board of directors, and the non-executive directors led by Mr. Valentine in his role as a non-executive Chairperson. Our board of directors has responsibility for the oversight of our risk management processes and, either as a whole or through its committees, regularly discusses with management our major risk exposures, their potential impact on our business and the steps we take to manage them. The risk oversight process includes receiving regular reports from board committees and members of senior management to enable our board of directors to understand our risk identification, risk management and risk mitigation strategies with respect to areas of potential material risk, including operations, finance, legal, regulatory, strategic, cybersecurity and reputational risk. 12 The audit committee reviews information regarding liquidity and operations as well as oversees our management of financial risks. Periodically, the audit committee reviews our policies with respect to risk assessment, risk management, loss prevention and regulatory compliance. Oversight by the audit committee includes direct communication with our external auditors, and discussions with